Kicman A T, Coutts S B, Cowan D A, Handelsman D J, Howe C J, Burring S, Wu F C
Drug Control Centre, King's College London, UK.
Clin Endocrinol (Oxf). 1999 May;50(5):661-8. doi: 10.1046/j.1365-2265.1999.00742.x.
The ratio of urinary testosterone (T) to epitestosterone (EpiT) is used to detect T abuse in sport. Also, plasma or urinary concentrations of EpiT have been measured to assess testicular steroidogenesis during hormonal male contraception. Further investigations are required to evaluate the relative contributions of the testis and adrenal to EpiT production. To this purpose, we have compared basal urinary EpiT glucuronide and plasma EpiT and the response to synthetic adrenocorticotrophic hormone (ACTH) stimulation between eugonadal and hypogonadal men.
The basal urinary excretion rate of EpiT glucuronide was determined in 34 eugonadal men. Six men, clinically diagnosed as hypogonadal, and 6 out of the 34 eugonadal men previously described, received an intramuscular injection of synthetic ACTH depot (1 mg) at 0800 h on two consecutive days. Blood samples were collected prior to and then at 1.5, 8, 24, 25.5, 32 and 48 h with respect to the first administration (0 h). 24-h urine specimens were collected from 0800 h on days 1 and 2 (baseline) and 3 and 4 (stimulation).
Plasma EpiT, T and cortisol were measured by RIA and urinary EpiT and T, following glucuronide hydrolysis, by gas chromatography-mass spectrometry (extract combines aglycones with a minor amount of urinary free steroids).
Basal excretion rates of EpiT glucuronide in eugonadal men (range: 62-751 nmol/24 h) were considerably greater than in hypogonadal men (range: 3-34 nmol/24 h). Mean basal plasma EpiT in eugonadal men (1.32 +/- 0.08 nmol/l) were greater than in hypogonadal men (0.68 +/- 0.04 nmol/l). In each group, synthetic ACTH stimulation increased plasma cortisol 4-fold. In eugonadal men, plasma and urinary EpiT were unchanged whereas plasma and urinary T glucuronide decreased in response to ACTH. In hypogonadal patients, ACTH increased plasma and urinary EpiT while plasma T remained unchanged.
The testes are the major source of epitestosterone, the adrenal contribution being relatively modest. Following adrenal stimulation, urinary epitestosterone glucuronide increases considerably in hypogonadal men but this increase is masked in eugonadal men because testicular production is probably suppressed by the ACTH-induced rise in cortisol. Activation of the adrenal cortex results in no change or only a small decrease in the urinary T/EpiT ratio in eugonadal men.
尿睾酮(T)与表睾酮(EpiT)的比值用于检测体育赛事中的睾酮滥用情况。此外,还通过测量血浆或尿液中EpiT的浓度来评估男性激素避孕期间的睾丸类固醇生成。需要进一步研究以评估睾丸和肾上腺对EpiT产生的相对贡献。为此,我们比较了性腺功能正常和性腺功能减退男性的基础尿EpiT葡萄糖醛酸苷、血浆EpiT以及对合成促肾上腺皮质激素(ACTH)刺激的反应。
测定了34名性腺功能正常男性的基础尿EpiT葡萄糖醛酸苷排泄率。6名临床诊断为性腺功能减退的男性以及之前描述的34名性腺功能正常男性中的6名,在连续两天的08:00时接受了一次肌肉注射长效合成ACTH(1毫克)。在首次给药(0小时)前以及给药后1.5、8、24、25.5、32和48小时采集血样。在第1天和第2天(基线)以及第3天和第4天(刺激期)的08:00时收集24小时尿液样本。
采用放射免疫分析法测定血浆EpiT、T和皮质醇,采用气相色谱 - 质谱法(提取物将苷元与少量尿游离类固醇结合)测定葡萄糖醛酸苷水解后的尿EpiT和T。
性腺功能正常男性的基础EpiT葡萄糖醛酸苷排泄率(范围:62 - 751纳摩尔/24小时)显著高于性腺功能减退男性(范围:3 - 34纳摩尔/24小时)。性腺功能正常男性的基础血浆EpiT平均水平(1.32±0.08纳摩尔/升)高于性腺功能减退男性(0.68±0.04纳摩尔/升)。在每组中,合成ACTH刺激使血浆皮质醇增加了4倍。在性腺功能正常男性中,血浆和尿EpiT未发生变化,而血浆和尿T葡萄糖醛酸苷对ACTH的反应降低。在性腺功能减退患者中,ACTH使血浆和尿EpiT增加,而血浆T保持不变。
睾丸是表睾酮的主要来源,肾上腺的贡献相对较小。肾上腺受到刺激后,性腺功能减退男性的尿表睾酮葡萄糖醛酸苷显著增加,但在性腺功能正常男性中这种增加被掩盖,因为ACTH诱导的皮质醇升高可能抑制了睾丸的生成。肾上腺皮质的激活导致性腺功能正常男性的尿T/EpiT比值无变化或仅略有下降。